Lucy Shapiro is Director at Anacor Pharmaceuticals, Inc. (ANAC). They have made 3 open-market trades across 2 companies since 2012, most recently 2024-06-18.
CIK 0001435944
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PACB | SELL | 2021-02-12 | 2021-02-17 | $50.40 | $10.2M | -15.6% | -19.9% | -41.6% |
| ANAC | SELL | 2014-12-10 | 2014-12-12 | $35.06 | $9.5M | -19.4% | +2.3% | +2.3% |
| ANAC | SELL | 2014-03-21 | 2014-03-25 | $21.14 | $1.7M | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2013-04-19 | 2013-04-19 | $8.02 | $200K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2013-03-22 | 2013-03-22 | $6.91 | $138K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2012-10-03 | 2012-10-05 | $6.68 | $200K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2012-09-28 | 2012-10-01 | $6.57 | $131K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2012-09-26 | 2012-09-28 | $6.58 | $66K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2012-09-21 | 2012-09-24 | $6.33 | $127K | -19.4% | +2.3% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.